U.S. issued AgriMetis’s L-Glufosinate process patent
Dec. 8, 2017
The patent claims are drawn to a two-step process for the production of substantially pure L-Glufosinate. This novel enzymatic process substantially increases the proportion of the active L-Glufosinate isomer in the mixture with D-Glufosinate.
Glu-L is an improved alternative to the commercial racemic glufosinate being manufactured and sold. The milestone achievement described in this patent exemplifies how the AgriMetis approach of combining biology and chemistry can lead to differentiated active ingredients in a well-studied agricultural crop protection market.
“We are especially proud of this important development as it will provide farmers the potential for more efficient and improved products for broad spectrum weed control,” said Steven Tuttle, President and CEO of AgriMetis.
More from AgroNews
- Health Canada proposes banning neonicotinoid insecticides in five years
- Brazil AgrochemShow 2018: Exemption of adjuvants from registration requires legal attention
- Most Chinese listed pesticide enterprises’ semi-annual performance in 2018 predicted to grow
- QSAR (Quantitative structure-activity relationship) Models: An Increasing Trend in Toxicological Evaluations for Pesticides Registration